CoChat

A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials

Open access
Fraser, Henrieta, Safinia, Niloufar, Grageda, Nathali, Thirkell, Sarah, Lowe, Katie, Fry, Laura J., Scottá, Cristiano, Hope, Andrew, Fisher, Christopher, Hilton, Rachel, Game, David, Harden, Paul, Bushell, Andrew, Wood, Kathryn, Lechler, Robert I., Lombardi, Giovanna · 2018 · Molecular Therapy - Methods & Clinical Development
Cited by 141

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The concept of regulatory T cell (Treg)-based immunotherapy has enormous potential for facilitating tolerance in autoimmunity and transplantation. Clinical translation of Treg cell therapy requires production processes that satisfy the rigors of Good Manufacturing Practice (GMP) standards. In this regard, we report our findings on the implementation of a robust GMP compliant process for the ex vivo expansion of clinical grade Tregs, demonstrating the feasibility of this developed process for the manufacture of a final product for clinical application. This Treg isolation procedure ensured the selection of a pure Treg population that underwent a 300-fold expansion after 36 days of culture, while maintaining a purity of more than 75% CD4 + CD25 + FOXP3 + cells and a suppressive function of above 80%. Furthermore, we report the successful cryopreservation of the final product, demonstrating the maintenance of phenotype and function. The process outlined in this manuscript has been implemented in the ONE study, a multicenter phase I/IIa clinical trial in which cellular therapy is investigated in renal transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2018.01.006

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 141

Metadata

Authors
Fraser, H., Safinia, N., Grageda, N., Thirkell, S., Lowe, K., Fry, L. J., Scottá, C., Hope, A., Fisher, C., Hilton, R., Game, D., Harden, P., Bushell, A., Wood, K., Lechler, R. I., & Lombardi, G.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2018-03
Volume
8
Pages
198-209
ISSN
2329-0501 (ISSN-L)
OpenAlex
W2786610929
Cited by
141
References
3
FWCI
4.71
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. https://app.cochat.ai/papers/10.1016/j.omtm.2018.01.006
The paper
Fraser, H., Safinia, N., Grageda, N., Thirkell, S., Lowe, K., Fry, L. J., Scottá, C., Hope, A., Fisher, C., Hilton, R., Game, D., Harden, P., Bushell, A., Wood, K., Lechler, R. I., & Lombardi, G. (2018). A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2018.01.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.